Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.
3 active warrant series covering 31,401,881 shares (~71.9% potential dilution); nearest expiry 2027-09-02.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.09 | Sep 2, 2027 326d | 7.2M | OTM | 16.5% | C$648K | Auto |
| warrant | $0.09 | Oct 31, 2027 385d | 21.9M | OTM | 50.1% | C$2.0M | Auto |
| warrant | $0.12 | Apr 13, 2028 550d | 2.3M | OTM | 5.3% | C$276K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
6 option grants covering 4,162,000 shares (~9.5% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.12 | Oct 22, 2028 742d | 750K | OTM | 1.7% | C$90K | Auto |
| option | $0.14 | Nov 18, 2030 1499d | 1.8M | OTM | 4.1% | C$243K | Auto |
| option | $1.20 | Jan 15, 2031 1557d | 320K | OTM | 0.7% | C$384K | Auto |
| option | $0.10 | Jan 20, 2031 1562d | 200K | OTM | 0.5% | C$20K | Auto |
| option | $1.85 | Mar 5, 2031 1606d | 92K | OTM | 0.2% | C$170K | Auto |
| option | $0.12 | Mar 10, 2031 1611d | 1.0M | OTM | 2.3% | C$120K | Auto |
43,687,521 shares outstanding, plus 31,401,881 from warrants and 4,162,000 from options — a fully diluted 79,251,402 shares, or ~81.4% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.